CellSeed

CellSeed Interest Expense

The Interest Expense of CellSeed (7776.T) as of Oct 27, 2026 is 777,000.00 JPY. In the previous year, Interest Expense was -1.16 M JPY — a change of -166.93% (higher).

Interest Expense

777,000.00JPY

YoY

-166.93%

Last updated:

Interest Expense of CellSeed is 2024 777,000.00 JPY. Interest Expense of CellSeed was 2023 -1.16 M JPY. It decreases by -166.93% higher compared to the previous year.

The CellSeed Interest Expense history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Expense
Date
Interest Expense
Jan 1, 2017
-600,000.00 JPY
Jan 1, 2018
-85,000.00 JPY
Jan 1, 2019
-47,000.00 JPY
Jan 1, 2020
-14.97 M JPY
Jan 1, 2021
-20.66 M JPY
Jan 1, 2022
706,000.00 JPY
Jan 1, 2023
-1.16 M JPY
Jan 1, 2024
777,000.00 JPY
The CellSeed Interest Expense history
YEARInterest ExpenseYoY
777,000.00JPY-166.93%
-1.16 MJPY-264.45%
706,000.00JPY-103.42%
-20.66 MJPY+38.04%
-14.97 MJPY+31,740.43%
-47,000.00JPY-44.71%
-85,000.00JPY-85.83%
-600,000.00JPY-95.37%
-12.96 MJPY-803.20%
1.84 MJPY+72.73%
1.07 MJPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CellSeed Stock analysis

What does CellSeed do? CellSeed Inc. generates revenue through two primary business segments. The Regenerative Medical Support segment sells temperature-responsive cell incubators developed by the company. These incubators are used in medical research and treatment applications. The Cell Sheet Regeneration Medical segment focuses on developing cell sheet regenerative medical products for therapeutic use. Both segments contribute to the company's revenue streams through product sales and research activities. The company serves medical institutions and research organizations requiring advanced regenerative medicine solutions. The Regenerative Medical Support segment's products are specifically designed for temperature-responsive cell culture applications. These incubators support cell growth and maintenance in controlled environments. The Cell Sheet Regeneration Medical segment's products involve innovative cell sheet technologies for tissue regeneration. These products are targeted at medical professionals and research facilities seeking advanced regenerative treatments. The company's focus on regenerative medicine positions it within the healthcare technology sector. CellSeed Inc. develops and sells its own proprietary products without external branding. The temperature-responsive cell incubators and cell sheet regenerative medical products are the company's core offerings. The company's business model relies on direct sales of these products to medical and research institutions. The products are sold under the company's own brand name without third-party branding. CellSeed is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CellSeed stock

Interest Expense of CellSeed is 777,000.00 JPY in 2024.

Interest Expense of CellSeed changed from -1.16 M JPY to 777,000.00 JPY, representing a -166.93% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Expense CellSeed since 2006 – with annual values, charts, and detailed analysis.

Interest expense represents the cost of borrowing. Higher interest expenses can indicate a highly leveraged company.

Interest Expense's JPY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Interest Expense's CellSeed historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — CellSeed

All Key Metrics — CellSeed